Core Viewpoint - The company announced that its drug, Anglatide Tablets (brand name: Anruwei®), is effective for treating adult patients with uncomplicated influenza A, showing strong inhibitory activity against various strains of influenza viruses, including those resistant to Oseltamivir and Baloxavir [2] Group 1 - The drug is specifically indicated for adult patients with uncomplicated influenza A [2] - Preclinical research indicates the drug's effectiveness against multiple influenza virus strains, including those resistant to other antiviral medications [2]

格隆汇11月19日丨众生药业(002317.SZ)在投资者互动平台表示，公司的昂拉地韦片（商品名：安睿威 ®）适用于成人单纯性甲型流感患者的治疗，临床前研究结果表明，对包括奥司他韦耐药株、高致病性 禽流感病毒株和巴洛沙韦耐药株等在内的多种不同亚型流感病毒株具有强大的抑制活性。 ...

Group 1 - The company is steadily advancing the commercialization of its influenza innovative drug, Amlodipine Tablets (brand name: Anruwei®) [2] - Amlodipine Tablets are currently available in public medical institutions across multiple provinces, major chain pharmacies, and online platforms such as JD.com, Tmall, and Meituan [2]